OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.


IASGO was established in Amsterdam in 1988. Today, we are favored to have solid IASGO areas in more than 70 nations, which significantly helps with evaluating instructive necessities. The primary objective of this association has been and remains globalization of medicinal information and skill through an all around organized and accurately sorted out arrangement of proceeded with therapeutic instruction. It is our conviction that medicinal learning and ability has a place with each person on this planet, and that must be accessible past any sort of separation, in light of individual institutional or national level, to each patient that takes a stab at survival in view of testing and life-undermining maladies.

With regards to this logic, we have been arranging, aside from our yearly World Congress, yearly Advanced Post-Graduate Training Courses for all the 28 years of our history. The fundamental attributes of this system have been the multi-disciplinary structure and multi-national span. These courses are constantly composed in close collaboration with national colleges or legislative powers, planning to overhaul the members in the most up to date improvements in the field of Surgical, Radiation and Medical Oncology, Endoscopy, and Interventional Radiology.

We will likely unite specialists in various zones of drug. This sort of mix offers open doors for remarkable expert communications and crossfertilization in the time of customized administration of stomach malignancies. With real advances in the range of restorative oncology in the course of the most recent two decades, we have now extended our system to incorporate courses on this point, and advantage from the backing of world-class staff from real scholarly focuses in Europe, USA, and Asia. The methodology is planned to advance the most recent leaps forward in translational malignancy research in parallel to the advances in surgery and gastroenterology.

Read More»